SCPX, XTIA and CRVO among mid-day movers
Seeking Alpha News (Mon, 20-May 1:12 PM ET)
Parkinson's-focused Serina Therapeutics, Enable Injections enter partnership
Seeking Alpha News (Wed, 15-May 8:26 AM ET)
Globe Newswire (Wed, 15-May 7:30 AM ET)
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
Globe Newswire (Tue, 14-May 4:05 PM ET)
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
Globe Newswire (Wed, 17-Apr 4:05 PM ET)
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
Serina Therapeutics trades on the AMEX stock market under the symbol SER.
As of May 20, 2024, SER stock price climbed to $10.45 with 60,728 million shares trading.
SER has a market cap of $26.13 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that SER belongs to (by Net Assets): VTI, VXF.
SER support price is $7.73 and resistance is $9.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SER stock will trade within this expected range on the day.